This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

ACT Oxycodone CR (2017-03-15)

Starting date:
March 15, 2017
Posting date:
March 22, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-62758

Affected Products

A. ACT Oxycodone CR 5 mg
B. ACT Oxycodone CR 10 mg
C. ACT Oxycodone CR 20 mg
D. ACT Oxycodone CR 40 mg
E. ACT Oxycodone CR 80 mg

Reason

Affected lot may contain incorrect strength.

Depth of distribution

Retailers
British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, Newfoundland, New Brunswick

Affected products

A. ACT Oxycodone CR 5 mg

DIN, NPN, DIN-HIM
DIN 02394170
Dosage form

Tablet (Extended-Release)

Strength

Oxycodone Hydrochloride 5 mg

Lot or serial number

K45622

Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

B. ACT Oxycodone CR 10 mg

DIN, NPN, DIN-HIM
DIN 02394189
Dosage form

Tablet (Extended-Release)

Strength

Oxycodone Hydrochloride 10 mg

Lot or serial number

K42363
K43687
K43689
K43690

Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

C. ACT Oxycodone CR 20 mg

DIN, NPN, DIN-HIM
DIN 02394197
Dosage form

Tablet (Extended-Release)

Strength

Oxycodone Hydrochloride 20 mg

Lot or serial number

K40870
K43160
K43686

Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

D. ACT Oxycodone CR 40 mg

DIN, NPN, DIN-HIM
DIN 02394200
Dosage form

Tablet (Extended-Release)

Strength

Oxycodone Hydrochloride 40 mg

Lot or serial number

K39640
K40899
K42362
K46810
K46811

Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

E. ACT Oxycodone CR 80 mg

DIN, NPN, DIN-HIM
DIN 02394219
Dosage form

Tablet (Extended-Release)

Strength

Oxycodone Hydrochloride 80 mg

Lot or serial number

K42365
K46813

Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA